Search results
Albert Bourla (Greek: Άλμπερτ Μπουρλά; born () October 21, 1961) is an American-Greek veterinarian and the chairman and chief executive officer of Pfizer, an American pharmaceutical company. He joined the company in 1993 and has held several executive roles across Pfizer's divisions.
As Chairman and Chief Executive Officer, Albert Bourla leads Pfizer in its purpose, “Breakthroughs that change patients’ lives,” with a focus on driving the scientific and commercial innovation needed to have a transformational impact on human health.
View Albert Bourla’s profile on LinkedIn, a professional community of 1 billion members. Albert Bourla leads Pfizer in its purpose, Breakthroughs that change patients’ lives…
- Pfizer
As Chairman and Chief Executive Officer, Albert Bourla leads Pfizer in its purpose, Breakthroughs that change patients’ lives, with a focus on driving the scientific and commercial innovation needed to have a transformational impact on human health.
Nov 9, 2021 · Albert Bourla became CEO of Pfizer in 2019 – the pinnacle of a career at Pfizer spanning more than two decades, multiple continents and several different business functions. When he took the helm of the global pharmaceutical company, he accelerated a transformation to become a more science-driven, innovative company.
The CEO of Pfizer on Developing a Vaccine in Record Time. Summary. On March 19, 2020, as Covid-19 swept across the world, Bourla challenged everyone at Pfizer and its partner BioNTech—a German ...
Apr 28, 2021 · Albert Bourla is ushering in a new era at Pfizer after leading a historic triumph with a COVID-19 vaccine. Andrew Dunn. Apr 28, 2021, 6:21 AM PDT. Albert Bourla, the CEO of Pfizer. Crystal...
Jan 9, 2024 · After a miserable 2023, Pfizer Inc. Chief Executive Officer Albert Bourla says he’s rapidly taking action to fix things and pegging the company’s hopes on one of the most competitive areas of...
Aug 13, 2021 · Pfizer chief Albert Bourla: ‘We are the most efficient vaccine machine’. The pharma boss on the Covid jab, his exchanges with Trump — and why suspending patents is no way to inoculate the...
May 2, 2024 · W hen Albert Bourla became CEO of Pfizer in 2019, just before the pandemic, he wanted to make Pfizer’s medicines more affordable to more patients. But COVID-19 delayed those plans when...
